Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07146295 | Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer(INFINITE) | recruiting | N/A | 1,760 | Isabelle HenskensOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT07563595 | Elacestrant in Patients With ER+ HER2- ESR1-mutated Locally Advanced or Metastatic Breast Cancer(ELENI) | recruiting | — | 500 | iOMEDICO AGINDUSTRY | 1 | Jun 25, 2026 |
| clinicaltrials |
| NCT05770531 | Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy | recruiting | Phase 2 | 160 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07387263 | Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing | recruiting | N/A | 180 | Unity Health TorontoOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07655934 | A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship(MILES) | recruiting | N/A | 100 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07659990 | RISS Versus SPSIP Block in Modified Radical Mastectomy(RSMRM) | recruiting | N/A | 80 | Ferit YetikOTHER_GOV | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07664579 | Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer | recruiting | — | 160 | City of Hope Medical CenterOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07666555 | A Phase II Clinical Study of the Efficacy and Safety of Culmerciclib Rechallenge in HR-positive, HER2-negative Breast Cancer Patients With Resistance to First-line Endocrine Therapy. | recruiting | Phase 2 | 98 | Fudan UniversityOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT04891068 | BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer(BRE-04) | recruiting | Phase 2 | 40 | University of Illinois at ChicagoOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT06048835 | Circulating Tumour Cells Characterization in Breast Cancer Patients(BioCellPhe) | recruiting | — | 80 | Istituti Clinici Scientifici Maugeri SpAOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT06258993 | A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation | recruiting | N/A | 85 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT06400563 | MRg-NIRS Imaging System Breast Cancer Trial(MRg-NIRS) | recruiting | N/A | 20 | Keith D. PaulsenOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT06993844 | Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 233 | Ensem TherapeuticsINDUSTRY | 2 | Jun 23, 2026 | clinicaltrials |
| NCT07046923 | A Study of LY4175408 in Participants With Advanced Cancer | recruiting | Phase 1 | 240 | Eli Lilly and CompanyINDUSTRY | 6 | Jun 23, 2026 | clinicaltrials |
| NCT07158021 | Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial | recruiting | Phase 2 | 75 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT07432633 | [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications | recruiting | Phase 1 / Phase 2 | 71 | Blue Earth DiagnosticsINDUSTRY | 1 | Jun 23, 2026 | clinicaltrials |
| NCT07662629 | Addtional Effect of Hyperbaric Oxygen to Programmed Physical Activity on Musckoloskeletal Pain in Breast Cancer Elderly | recruiting | N/A | 40 | Cairo UniversityOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT05573126 | Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer | recruiting | Phase 1 / Phase 2 | 95 | Ellipses PharmaINDUSTRY | 3 | Jun 22, 2026 | clinicaltrials |
| NCT05696626 | Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation(ELAINEIII) | recruiting | Phase 3 | 600 | LeonaBioINDUSTRY | 17 | Jun 22, 2026 | clinicaltrials |
| NCT06545331 | Study of XB010 in Subjects With Solid Tumors | recruiting | Phase 1 | 396 | ExelixisINDUSTRY | 2 | Jun 22, 2026 | clinicaltrials |
| NCT07084519 | Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction | recruiting | Phase 3 | 506 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT07467824 | Impact of Prehabilitation and Comprehensive Follow-up in Women With Breast Cancer(PREACT) | recruiting | N/A | 66 | European University Miguel de CervantesOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT04986579 | Scalp Cooling in MBC | recruiting | Phase 2 | 120 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT07503808 | A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types | recruiting | Phase 1 | 150 | IDEAYA BiosciencesINDUSTRY | 1 | Jun 18, 2026 | clinicaltrials |
| NCT07658170 | Evaluation of the Efficacy and Safety of Using Platelet-rich Fibrin (PRF)-Based Lipobolus for the Immediate Reconstruction of Defects After Breast-conserving Resection for Breast Cancer (Minimally Invasive Primary Immediate Grafting)(MINIPIG) | recruiting | N/A | 30 | The Leningrad Regional Clinical HospitalOTHER_GOV | 1 | Jun 18, 2026 | clinicaltrials |
| NCT04614194 | Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib | recruiting | Phase 2 | 60 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT04937309 | Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea(SILENCE) | recruiting | N/A | 338 | University Hospital, ToursOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT05029999 | CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer | recruiting | Phase 1 | 30 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT05293470 | A Post Marketing Surveillance on Piqray in Korea | recruiting | — | 900 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 17, 2026 | clinicaltrials |
| NCT06892093 | Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients | recruiting | N/A | 308 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT06994377 | Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy(EIRENE) | recruiting | — | 1,000 | European Institute of OncologyOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT07261631 | Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors | recruiting | Phase 1 | 180 | Novartis PharmaceuticalsINDUSTRY | 6 | Jun 17, 2026 | clinicaltrials |
| NCT07653893 | A Phase II Observational Clinical Study on the Relationship Between Cerebrospinal Fluid Drug Concentration and Efficacy of Trastuzumab Deruxtecan in Central Nervous System Metastatic Breast Cancer(BCBM006) | recruiting | — | 60 | Fudan UniversityOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT04517838 | Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer | recruiting | — | 230 | Mayo ClinicOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT06028022 | Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors | recruiting | Phase 2 | 80 | Mayo ClinicOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT07597629 | A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer | recruiting | Phase 2 | 36 | CSPC Megalith Biopharmaceutical Co.,Ltd.INDUSTRY | 1 | Jun 16, 2026 | clinicaltrials |
| NCT07650305 | Bilevel Erector Spinae Plane Block Versus Pectoserratus Block for Analgesia in Modified Radical Mastectomy | recruiting | N/A | 60 | National Cancer Institute, EgyptOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT05704283 | 3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer | recruiting | Early Phase 1 | 55 | Mayo ClinicOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT06930521 | JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year(JUSTIFY) | recruiting | N/A | 300 | Women's College HospitalOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT06960707 | Two Versus One Week Breast Radiotherapy (RT)(PRATO) | recruiting | Phase 3 | 400 | Weill Medical College of Cornell UniversityOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT07474090 | Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial(STEPS-BC) | recruiting | N/A | 120 | Wake Forest University Health SciencesOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT07557654 | Opportunistic Breast Cancer Screening Using Non-Contrast Chest CT(OPBCS-CT) | recruiting | — | 5,000 | Fudan UniversityOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT07647016 | Trastuzumab Deruxtecan Plus ivonescImab for Hormone Receptor-positive HER2 Negative Advanced Breast Cancer Study | recruiting | Phase 2 | 53 | Fudan UniversityOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT07647263 | Trastuzumab Rezetecan Neoadjuvant Therapy in THP-Insensitive HER2-Positive Early Breast Cancer | recruiting | Phase 2 | 124 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT00991094 | Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy | recruiting | — | 5,000 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT03572374 | Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job | recruiting | N/A | 546 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT05178498 | Impact of Dietary Inflammatory Potential on Breast Cancer Risk | recruiting | — | 960 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT05950945 | Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer | recruiting | Phase 3 | 250 | Daiichi SankyoINDUSTRY | 10 | Jun 12, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jun 25, 2026source: clinicaltrials